Lupus patients may get safer steroid tapering plans
NCT ID NCT03187743
First seen Mar 11, 2026 · Last updated May 16, 2026 · Updated 7 times
Summary
This study tested a personalized method for reducing corticosteroid doses in people with systemic lupus. 72 participants had their prednisone dose and tapering schedule adjusted based on individual needs. The goal was to learn how the body processes the drug to make tapering safer and more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Necker Enfants Malades
Paris, Paris, 75015, France
Conditions
Explore the condition pages connected to this study.